- Published at
- by gurufocus.com
positive
positive
Immunovant Inc (IMVT) Announces Investor Webcast to Discuss Phase 3 and Phase 2b Study Results
Immunovant Inc (IMVT), a clinical-stage immunology company focused on developing therapies for autoimmune diseases, has announced an investor webcast scheduled